Patent 7740830 was granted and assigned to Cancer Research Technology Limited on June, 2010 by the United States Patent and Trademark Office.
The present invention relates to endothelial cell-specific genes and encoded polypeptides and materials and uses thereof in the imaging, diagnosis and treatment of conditions involving the vascular endothelium.